Sarborg, a technology-driven company that integrates mathematical algorithm-led approaches with complementary cybernetics to optimize decision-making processes, is pleased to announce the successful closing of its $10 million Seed funding round, led by third-party investor, Corvus Capital.

Sarborg is a technology-driven company that integrates proprietary AI-agents and mathematical algorithm-based approaches with complementary cybernetics and extensive neural networks, to optimize decision-making processes. Its current principal vertical is focused on evaluating drug repurposing matching unique drug and disease signatures for pharmaceutical companies, leveraging machine learning and algorithmic strategies to enhance asset portfolio management and improve the probability of success in clinical trials. The Company is planning its expansion into further analytic areas beyond pharmaceuticals.